Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing
Bria-Pros+ is based on BriaCell's next generation personalized immunotherapy platform • Bria-Pros+ is capable of activating multiple types of immune cells, including helper T cells, cytotoxic (killer) T cells and natural killer cells PHILADELPHIA and VANCOUVER, British Columbia, Feb. 06, 2024…#briacell #briapros #philadelphia #britishcolumbia #gmp #sitc #williamvwilliams #hla #classicalnk #nkt (Source: Reuters: Health)
Source: Reuters: Health - February 6, 2024 Category: Consumer Health News Source Type: news
Comparing side effects after prostate cancer treatment
Men with cancer confined to the prostate experienced different long-term side effects depending on the type of treatment received. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - February 6, 2024 Category: Consumer Health News Source Type: news
Prostate cancer survival rate: Outlook for different stages of the disease
Prostate cancer survival depends on many factors, but especially what stage the disease is at. (Source: Daily Express - Health)
Source: Daily Express - Health - February 5, 2024 Category: Consumer Health News Source Type: news
King Charles III Diagnosed With Cancer, Buckingham Palace Says
The #UK's #KingCharles III has been diagnosed with #cancer, #BuckinghamPalace said, and the 75-year-old #monarch will now receive treatment during which he will not be carrying out public duties. The palace did not specify the type of cancer found, except to rule out prostate cancer. #worldnews…#kingcharlesiii #buckinghampalace #subscribe #bloombergoriginals #bloombergquicktake #breakingnewson (Source: Reuters: Health)
Source: Reuters: Health - February 5, 2024 Category: Consumer Health News Source Type: news
ACS, Pfizer ink $15M initiative to mitigate cancer care disparities
The American Cancer Society (ACS) and Pfizer have inked a three-year, $15 million initiative to mitigate cancer care disparities.
Called "Change the Odds: Uniting to Improve Cancer Outcomes," the project is intended to serve "medically underrepresented communities across the U.S. by enhancing awareness of and access to cancer screenings [particularly for breast and prostate cancer], clinical trial opportunities, and patient support and comprehensive navigation," the ACS and Pfizer said. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 5, 2024 Category: Radiology Authors: AuntMinnie.com staff writers Tags: Industry News Source Type: news
Adding Apalutamide Boosts PSA Control in Prostate Cancer Adding Apalutamide Boosts PSA Control in Prostate Cancer
Adding apalutamide to androgen deprivation therapy (ADT) prolongs prostate-specific antigen progression-free survival in patients with biochemically recurrent prostate cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 5, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Cancer screening hasn't rebounded to prepandemic levels
Preventive health screenings, including those for screening mammography, have not rebounded to pre-COVID-19 pandemic levels, a new study published February 2 in JAMA Health Forum found.
Researchers led by Rishi Wadhera, MD, from Beth Israel Deaconess Medical Center in Boston found that eligible adults were significantly less likely to receive breast cancer screening and other types of health screening in 2021 compared with 2019.
“These findings support the need for public health efforts to increase the use of preventive health screenings among eligible U.S. adults,” Wadhera and co-authors wrote.
Previous research ha...
Source: AuntMinnie.com Headlines - February 2, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Subspecialties Breast Imaging Source Type: news
Cardiorespiratory Fitness May Cut Prostate Cancer Risk Cardiorespiratory Fitness May Cut Prostate Cancer Risk
A new study adds to evidence that exercise reduces all-cause mortality risk across many cancer types, including prostate.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 2, 2024 Category: Consumer Health News Tags: Urology Source Type: news
Improved Fitness May Reduce Prostate Cancer Risk
(MedPage Today) -- Improving cardiorespiratory fitness may lower men's prostate cancer risk, results from a Swedish study suggested.
The retrospective study showed that an overall increase in absolute cardiorespiratory fitness (as measured by... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 1, 2024 Category: Hematology Source Type: news
Global cancer burden grows as NHS England launches national gene testing programme
Ahead of World Cancer Day on 4 February, the World Health Organization (WHO) has released new figures showing that the global cancer burden is growing. The survey undertaken by the WHO’s cancer agency, the International Agency for Research on Cancer (IARC), shows a growing need for more cancer-related health services worldwide. Figures from 2022 show... Read moreThe post Global cancer burden grows as NHS England launches national gene testing programme appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - February 1, 2024 Category: Nursing Authors: Carolyn Scott Tags: Cancer BRCA gene testing Breast cancer colorectal cancer lung cancer prostate cancer stomach cancer Source Type: news
World Cancer Day 2024
Cancer is a major contributor to global mortality, causing about 1 in every 6 deaths and affecting nearly every household (1). Globally, there were an estimated 20 million new cases of cancer and 9.7 million deaths from cancer in 2022. The cancer burden will increase by about 77% by 2050, further straining health systems, people and communities (2).
In the WHO Eastern Mediterranean Region alone, more than 788 000 people were diagnosed with cancer in 2022. This number is projected to double to reach 1.57 million cases by 2045, because of population growth and, more importantly, the high prevalence of cancer risk factors in...
Source: WHO EMRO News - February 1, 2024 Category: Middle East Health Source Type: news
Top Causes of Early Noncancer Deaths in Advanced GU Cancers Top Causes of Early Noncancer Deaths in Advanced GU Cancers
Sepsis was the leading reason for early noncancer deaths in patients with metastatic bladder, kidney, or prostate cancer, a recent analysis found.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Small PFS Gain in Metastatic Prostate Cancer With TKI, ICI Small PFS Gain in Metastatic Prostate Cancer With TKI, ICI
Men with metastatic castration-resistant prostate cancer had a slight but significant improvement in progression-free survival with a TKI plus immunotherapy vs hormonal therapy.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Olaparib combo improves PFS in metastatic prostate cancer Olaparib combo improves PFS in metastatic prostate cancer
Frontline olaparib plus abiraterone/prednisone combo improves survival in patients with metastatic castration-resistant prostate cancer.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 1, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
Change in Cardiorespiratory Fitness Linked to Prostate Cancer Incidence
WEDNESDAY, Jan. 31, 2024 -- Change in cardiorespiratory fitness (CRF) is inversely associated with the risk for prostate cancer incidence, but not mortality, according to a study published online Jan. 30 in the British Journal of Sports... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 31, 2024 Category: Pharmaceuticals Source Type: news
